An international team of researchers has modified a probiotic yeast to make it safer for use by immunocompromised people, older adults and infants. Testing in an animal model found that the modified yeast is less likely to cause infection than unmodified strains of the same organism. The associated research paper is published in the journal Communications Biology.
